Entrada Therapeutics (TRDA) Accounts Payables (2020 - 2026)
Entrada Therapeutics' Accounts Payables came in at $3.75 million for Q2 2026, up 101.7% from $1.86 million a year earlier and up 27.8% from the prior quarter.
Powered by 
Analysis
Entrada Therapeutics (TRDA) Accounts Payables (2020 - 2026) Analysis & Trends
At the end of FY2025, Entrada Therapeutics' Accounts Payables was $2.29 million, down 46.3% from FY2024.
- Accounts Payables carries a five-year compound annual growth rate of 7.4% (FY2020 to FY2025).
- Going back by year, Accounts Payables was $4.26 million in FY2024 (+30.0%), $3.28 million in FY2023 (-45.3%), $5.99 million in FY2022 (+748.4%) and $706,000 in FY2021 (-55.9%).
- The Q2 2026 figure represents the highest quarterly Accounts Payables since Q4 2024.
- Year-over-year, Accounts Payables increased in six of the last eight quarters, with growth averaging 42.0%.
- The fastest year-over-year change in Accounts Payables over five years came in Q4 2022 (growth of 748.4%), and the weakest in Q1 2024 (a decline of 61.0%).
- Business Quant data shows TRDA's Accounts Payables at $2.93 million (Q1 2026), $2.29 million (Q4 2025) and $3.17 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Entrada Therapeutics | 242.19 Mn | 242.19 Mn | - | 3.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.75 Mn |
| Mar 31, 2026 | 2.93 Mn |
| Dec 31, 2025 | 2.29 Mn |
| Sep 30, 2025 | 3.17 Mn |
| Jun 30, 2025 | 1.86 Mn |
| Mar 31, 2025 | 2.19 Mn |
| Dec 31, 2024 | 4.26 Mn |
| Sep 30, 2024 | 1.29 Mn |
| Jun 30, 2024 | 1.64 Mn |
| Mar 31, 2024 | 2.53 Mn |
| Dec 31, 2023 | 3.28 Mn |
| Sep 30, 2023 | 752,000.00 |
| Jun 30, 2023 | 2.42 Mn |
| Mar 31, 2023 | 6.47 Mn |
| Dec 31, 2022 | 5.99 Mn |
| Sep 30, 2022 | 1.34 Mn |
| Jun 30, 2022 | 4.62 Mn |
| Mar 31, 2022 | 2.93 Mn |
| Dec 31, 2021 | 706,000.00 |
| Sep 30, 2021 | 2.28 Mn |
API Access
Entrada Therapeutics Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=TRDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "TRDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=TRDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();